A50 — Thomson Medical Cashflow Statement
0.000.00%
- SG$1.14bn
- SG$2.19bn
- SG$351.15m
- 26
- 17
- 63
- 24
Annual cashflow statement for Thomson Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 18 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -79.5 | 26.2 | 69.3 | 55.2 | 30.6 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 127 | 21.9 | 21.9 | 28.7 | 18.8 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4.86 | -4.8 | -16.3 | -16.4 | 6.46 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 78.6 | 61.3 | 92.8 | 88.6 | 83.3 |
Capital Expenditures | -75.4 | -37.3 | -27.8 | -11.2 | -26.9 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -25.2 | -0.282 | -1.68 | -2.18 | -463 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | -101 | -37.6 | -29.4 | -13.4 | -490 |
Financing Cash Flow Items | -43.5 | -21.2 | -23.3 | -32.3 | -58.6 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 30.9 | -58.8 | -23.5 | 54.2 | 281 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.6 | -35.4 | 38.8 | 125 | -126 |